CODING SEQUENCES OF THE HUMAN BRCA1 GENE

The invention relates to isolated coding sequences and to the protein sequences they code for. This invention is directed to three coding sequences of the BRCA1 gene. The three coding sequences, BRCA1 (omi1), BRCA1 (omi2), and BRCA1 (omi3) and their frequencies of occurrence are provided together wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OLSON, SHERI J, ALVARES, CHRISTOPHER P, CRITZ, BRENDA S, ZENG, BIN, MURPHY, PATRICIA D, SCHELTER, DENISE B, ALLEN, ANTONETTE C
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to isolated coding sequences and to the protein sequences they code for. This invention is directed to three coding sequences of the BRCA1 gene. The three coding sequences, BRCA1 (omi1), BRCA1 (omi2), and BRCA1 (omi3) and their frequencies of occurrence are provided together with the protein sequences they code for. Another aspect of this invention is a method of determining the consensus sequence for any gene. Another aspect of the invention is a method of identifying an individual having an increased genetic susceptibility to breast or ovarian cancer because they have inherited a causative mutation in their BRCA1 gene. This invention is also related to a method of performing gene therapy with any of the isolated BRDCA1 coding sequences.